Tower Research Capital (TRC)’s Evoke Pharma EVOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.17K | Buy |
1,988
+1,775
| +833% | +$4.62K | ﹤0.01% | 4220 |
|
2025
Q1 | $586 | Buy |
+213
| New | +$586 | ﹤0.01% | 4864 |
|
2024
Q4 | – | Sell |
-816
| Closed | -$3.88K | – | 5771 |
|
2024
Q3 | $3.88K | Buy |
816
+193
| +31% | +$919 | ﹤0.01% | 4746 |
|
2024
Q2 | $3.96K | Buy |
623
+6
| +1% | +$38 | ﹤0.01% | 4840 |
|
2024
Q1 | $4.52K | Buy |
617
+80
| +15% | +$586 | ﹤0.01% | 4668 |
|
2023
Q4 | $6.77K | Buy |
537
+54
| +11% | +$681 | ﹤0.01% | 4699 |
|
2023
Q3 | $7.99K | Buy |
483
+18
| +4% | +$298 | ﹤0.01% | 4411 |
|
2023
Q2 | $9.21K | Buy |
465
+133
| +40% | +$2.63K | ﹤0.01% | 4295 |
|
2023
Q1 | $8K | Buy |
332
+261
| +368% | +$6.29K | ﹤0.01% | 4623 |
|
2022
Q4 | $2K | Sell |
71
-116
| -62% | -$3.27K | ﹤0.01% | 5357 |
|
2022
Q3 | $4K | Sell |
187
-13
| -7% | -$278 | ﹤0.01% | 5246 |
|
2022
Q2 | $8K | Buy |
200
+125
| +167% | +$5K | ﹤0.01% | 4673 |
|
2022
Q1 | $5K | Buy |
75
+46
| +159% | +$3.07K | ﹤0.01% | 5043 |
|
2021
Q4 | $2K | Buy |
+29
| New | +$2K | ﹤0.01% | 5617 |
|
2021
Q1 | – | Sell |
-8
| Closed | -$3K | – | 5472 |
|
2020
Q4 | $3K | Sell |
8
-42
| -84% | -$15.8K | ﹤0.01% | 4792 |
|
2020
Q3 | $34K | Buy |
+50
| New | +$34K | ﹤0.01% | 3681 |
|
2016
Q3 | – | Sell |
-1
| Closed | -$1K | – | 3842 |
|
2016
Q2 | $1K | Sell |
1
-6
| -86% | -$6K | ﹤0.01% | 4144 |
|
2016
Q1 | $5K | Sell |
7
-25
| -78% | -$17.9K | ﹤0.01% | 2675 |
|
2015
Q4 | $15K | Buy |
+32
| New | +$15K | ﹤0.01% | 1604 |
|
2015
Q3 | – | Sell |
-10
| Closed | -$7K | – | 4217 |
|
2015
Q2 | $7K | Buy |
10
+9
| +900% | +$6.3K | ﹤0.01% | 2988 |
|
2015
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 4050 |
|
2014
Q4 | $1K | Sell |
1
-2
| -67% | -$2K | ﹤0.01% | 3626 |
|
2014
Q3 | $3K | Buy |
3
+2
| +200% | +$2K | ﹤0.01% | 3599 |
|
2014
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 3652 |
|